| Specialty Retail Industry | Consumer Discretionary Sector | Taehong Choi CEO | KRX SM Exchange | KR7293480000 ISIN |
| KR Country | - Employees | 29 Dec 2025 Last Dividend | 28 Apr 2021 Last Split | - IPO Date |
Hana Pharm Co., Ltd. is a distinguished player in the global pharmaceutical industry, with its roots planted firmly in South Korea. Since its inception in 1958, the company has been dedicated to the development and provision of an extensive range of pharmaceutical products. Catering to diverse health needs, Hana Pharm extends its services both domestically and internationally, reinforcing its presence with a solid foundation headquartered in the bustling city of Seoul, South Korea. This established pharmaceutical entity is at the forefront of advancing healthcare solutions, through innovation, wide-ranging product offerings, and a clear commitment to enhancing patient care and well-being.
Hana Pharm Co., Ltd. boasts a comprehensive portfolio of pharmaceutical products, addressing a myriad of health conditions and therapeutic areas: